Allergan, Inc.
Enhanced bimatoprost ophthalmic solution
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
Allergan Inc.
A A A A A A A A A A
A61K A61K A61K A61K A61K A61P A61K A61K A61P A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Chin-Ming Rhett M. James N. R. Scott Joan-En
Chang Schiffman Chang Jordan Chang-Lin